Hemo Organic [HEMORGANIC] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison
Hemo Organic
BSE
Loading...
Divi's Laboratories
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Hemo Organic wins in 7 metrics, Divi's Laboratories wins in 11 metrics, with 0 ties. Divi's Laboratories appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Hemo Organic | Divi's Laboratories | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 44.87 | 69.80 | Hemo Organic |
| Price-to-Book Ratio | -21.72 | 10.74 | Hemo Organic |
| Debt-to-Equity Ratio | -9.77 | 0.03 | Hemo Organic |
| PEG Ratio | 0.02 | 2.64 | Hemo Organic |
| EV/EBITDA | 184.53 | 51.05 | Divi's Laboratories |
| Profit Margin (TTM) | 3.28% | 23.89% | Divi's Laboratories |
| Operating Margin (TTM) | -6,026.32% | 25.60% | Divi's Laboratories |
| EBITDA Margin (TTM) | N/A | 25.60% | N/A |
| Return on Equity | -108.18% | 14.64% | Divi's Laboratories |
| Return on Assets (TTM) | 3.29% | 12.94% | Divi's Laboratories |
| Free Cash Flow (TTM) | $-3.62M | $2.15B | Divi's Laboratories |
| Dividend Yield | N/A | 0.91% | N/A |
| 1-Year Return | -20.17% | 13.75% | Divi's Laboratories |
| Price-to-Sales Ratio (TTM) | 1.44 | 16.66 | Hemo Organic |
| Enterprise Value | $47.24M | $1,564.62B | Divi's Laboratories |
| EV/Revenue Ratio | 1.90 | 16.21 | Hemo Organic |
| Gross Profit Margin (TTM) | 26.32% | 60.33% | Divi's Laboratories |
| Revenue per Share (TTM) | $7 | $363 | Divi's Laboratories |
| Earnings per Share (Diluted) | $0.23 | $86.78 | Divi's Laboratories |
| Beta (Stock Volatility) | -0.06 | 0.23 | Hemo Organic |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Hemo Organic vs Divi's Laboratories Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Hemo Organic | -9.83% | -2.42% | -4.34% | -11.05% | -0.75% | -18.99% |
| Divi's Laboratories | 1.44% | 2.88% | 1.98% | -4.51% | 6.56% | 2.09% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Hemo Organic | -20.17% | -59.74% | -20.17% | -56.11% | -92.59% | 39.04% |
| Divi's Laboratories | 13.75% | 70.21% | 102.56% | 452.88% | 1,641.82% | 9,004.26% |
News Based Sentiment: Hemo Organic vs Divi's Laboratories
Hemo Organic
News sentiment data is not available for Hemo Organic at this time.
Divi's Laboratories
News based Sentiment: MIXED
September presented a mixed bag for Divi's Laboratories, with sequential declines in financial performance and a downgrade offset by continued strength in custom synthesis and a positive outlook from Jefferies. The insider selling and neutral analyst rating add to the complexity, making it a significant but uncertain month for investors.
Performance & Financial Health Analysis: Hemo Organic vs Divi's Laboratories
| Metric | HEMORGANIC | DIVISLAB |
|---|---|---|
| Market Information | ||
| Market Cap | ₹33.48M | ₹1.62T |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 3,947 | 357,978 |
| 90 Day Avg. Volume | 2,540 | 424,293 |
| Last Close | ₹9.26 | ₹6,200.00 |
| 52 Week Range | ₹8.05 - ₹13.70 | ₹4,955.00 - ₹7,071.50 |
| % from 52W High | -32.41% | -12.32% |
| All-Time High | ₹2,386.00 (Apr 21, 2008) | ₹7,071.50 (Jul 08, 2025) |
| % from All-Time High | -99.61% | -12.32% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -1.00% | 0.14% |
| Quarterly Earnings Growth | N/A | 0.27% |
| Financial Health | ||
| Profit Margin (TTM) | 0.03% | 0.24% |
| Operating Margin (TTM) | -60.26% | 0.26% |
| Return on Equity (TTM) | -1.08% | 0.15% |
| Debt to Equity (MRQ) | -9.77 | 0.03 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹-0.44 | ₹563.87 |
| Cash per Share (MRQ) | ₹0.03 | ₹132.86 |
| Operating Cash Flow (TTM) | ₹-38,918,000 | ₹19.67B |
| Levered Free Cash Flow (TTM) | ₹1.64M | ₹21.91B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.91% |
| Last 12-Month Dividend | N/A | ₹60.00 |
Valuation & Enterprise Metrics Analysis: Hemo Organic vs Divi's Laboratories
| Metric | HEMORGANIC | DIVISLAB |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 44.87 | 69.80 |
| Forward P/E | N/A | 107.58 |
| PEG Ratio | 0.02 | 2.64 |
| Price to Sales (TTM) | 1.44 | 16.66 |
| Price to Book (MRQ) | -21.72 | 10.74 |
| Market Capitalization | ||
| Market Capitalization | ₹33.48M | ₹1.62T |
| Enterprise Value | ₹47.24M | ₹1.56T |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.90 | 16.21 |
| Enterprise to EBITDA | 184.53 | 51.05 |
| Risk & Other Metrics | ||
| Beta | -0.06 | 0.23 |
| Book Value per Share (MRQ) | ₹-0.44 | ₹563.87 |
Financial Statements Comparison: Hemo Organic vs Divi's Laboratories
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | HEMORGANIC | DIVISLAB |
|---|---|---|
| Revenue/Sales | ₹19,000 | ₹24.10B |
| Cost of Goods Sold | ₹14,000 | ₹9.56B |
| Gross Profit | ₹5,000 | ₹14.54B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹-1.15M | ₹6.17B |
| EBITDA | ₹-1.14M | ₹8.48B |
| Pre-Tax Income | ₹-1.15M | ₹7.33B |
| Income Tax | ₹-288,000 | ₹1.88B |
| Net Income (Profit) | ₹-857,000 | ₹5.45B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | HEMORGANIC | DIVISLAB |
|---|---|---|
| Cash & Equivalents | ₹87,000 | ₹4.15B |
| Total Current Assets | ₹46.94M | ₹100.81B |
| Total Current Liabilities | ₹36.47M | ₹14.52B |
| Long-Term Debt | ₹14.80M | ₹20.00M |
| Total Shareholders Equity | ₹-1.52M | ₹149.69B |
| Retained Earnings | N/A | ₹134.00B |
| Property, Plant & Equipment | ₹20,000 | ₹3.19B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | HEMORGANIC | DIVISLAB |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | HEMORGANIC | DIVISLAB |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 3,947 | 357,978 |
| Average Daily Volume (90 Day) | 2,540 | 424,293 |
| Shares Outstanding | 3.47M | 265.47M |
| Float Shares | 1.92M | 120.77M |
| % Held by Insiders | 0.42% | 0.52% |
| % Held by Institutions | 0.00% | 0.29% |
Dividend Analysis & Yield Comparison: Hemo Organic vs Divi's Laboratories
| Metric | HEMORGANIC | DIVISLAB |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹60.00 |
| Last 12-Month Dividend Yield | N/A | 0.91% |
| 3-Year Avg Annual Dividend | N/A | ₹50.00 |
| 3-Year Avg Dividend Yield | N/A | 0.70% |
| 3-Year Total Dividends | N/A | ₹150.00 |
| Ex-Dividend Date | N/A | Jul 25, 2025 |